Common Cancers In Urology

Kidney Cancer

Kidney cancer is the ninth most commonly occurring cancer in men and the 14th most commonly occurring cancer in women. Renal cell carcinoma (RCC), also known as renal cell cancer or renal cell adenocarcinoma, is the most common type of kidney cancer (about 9 out of 10 kidney cancers). They arise from structures called Renal Tubules which filter fluids in the kidney before the waste (urine) is discharged into the bladder. About 5 to 10 percent of kidney cancers are Transitional cell cancers (TCC). These don’t start in the kidney itself, but in the lining of the renal pelvis (where the ureters meet the kidneys). These are usually more aggressive than RCCs. Most people diagnosed with kidney cancer are between 65 and 74. Kidney cancer is twice as common in men than in women, and African Americans, American Indian and Alaskan Natives are more likely to be diagnosed.

What are the risk factors for RCC?

The following risk factors have been associated with RCCs:

  • Smoking tobacco
  • Being obese or overweight
  • Having hypertension (high blood pressure)
  • Overusing pain medications, including over-the-counter medications, for extended periods of time
  • Having a family history of renal cancer
  • Having certain genetic conditions, such as von Hippel-Lindau disease (VHL), tuberous sclerosis, or hereditary leiomyomatosis and renal cell carcinoma (HLRCC) 
  • Being exposed to certain environmental toxins, such as trichloroethylene
  • Renal failure

How is RCC diagnosed?

Many early kidney cancers are discovered during testing for other reasons. A urine sample may show blood, or a blood test may detect anemia. An imaging study of the abdomen for unrelated symptoms may reveal kidney cancer.

If doctors suspect kidney cancer, imaging studies are important for diagnosis. In some cases, kidney cancer may be diagnosed with imaging studies alone.

These include:

If surgery is recommended, the diagnosis also may be confirmed post-op by looking at cancer cells under a microscope, called pathologic diagnosis. Kidney cancer also may be confirmed with a needle biopsy.

Learn more about diagnosing kidney cancer

What are the treatment options available?

Surgery is the first-line treatment option for most patients with renal cell carcinoma. Other treatment options for all types of kidney cancer include:

Learn more about treatments for kidney cancer

Prostate Cancer

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. The American Cancer Society (ACS) estimates that about 248,530 new cases of prostate cancer will be diagnosed in 2021. Prostate cancer usually grows very slowly, and finding and treating it before symptoms occur may not improve men’s health or help them live longer.

Some prostate cancers are aggressive. Approximately one in every 41 men diagnosed will die from the disease, according to the ACS. Black men are reportedly more prone to developing fast-growing prostate cancers that start causing problems earlier and are harder to treat.

What are the risk factors of prostate cancer?

Prostate cancer is rarely diagnosed in men younger than 40. By age 50, men undergo changes in the size and shape of the cells in the prostate. Understanding whether these changes are signs of a tumor and knowing your risk for developing prostate cancer are important steps in protecting your health.

Besides age, other risk factors for prostate cancer include:

  • Race: Black men are more likely to develop prostate cancer than men of other races—and are more likely to die from the disease.
  • Family history: The risk of developing prostate cancer is higher among people who have an immediate family member, such as a father, brother or son, who had or currently has prostate cancer.
  • Inherited genetic changes: Several inherited mutations are associated with a higher risk of prostate cancer. Mutations in the BRCA1 or BRCA2 genes are one example. (BRCA mutations are well-known for their link to breast cancer and ovarian cancer in women.) An inherited condition called Lynch syndrome is also associated with a higher risk of prostate cancer, among other types of cancer.

What are the common signs and symptoms of prostate cancer?

In the early stages, prostate cancer usually doesn’t show symptoms. However, as prostate cancer grows, it may lead to:

  • Trouble initiating urination
  • Weak, slow or interrupted urine flow
  • Frequent need to urinate, particularly at night
  • Difficulty emptying the bladder fully
  • Incontinence
  • Blood in urine or semen
  • Back, hip, chest or pelvis pain that doesn’t subside
  • A burning sensation or pain during urination
  • Difficulty getting an erection

Patients who develop new or concerning symptoms should consult with their doctor or urologist.

Learn more about the signs and symptoms of prostate cancer

How is Prostate Cancer diagnosed?

Symptoms are often absent in the early stages of prostate cancer. Many cases are discovered through routine screening tests. Getting screened for prostate cancer is an individual decision. It may help to discuss the risks and benefits with a doctor.

Screening for prostate cancer usually involves the following tests:

If either of these suggests the possibility of prostate cancer, doctors typically perform additional tests before making a diagnosis.
The only way to know for sure whether a tumor is cancerous is by examining cells under a microscope, a procedure also known as a prostate biopsy.


Learn about diagnostic procedures for prostate cancer

What are the treatment options?

Deciding on prostate cancer treatment is a personal decision made between a patient and his care team. Factors such as preferences, age, health history and the cancer stage all play a role in the decision-making process.
Treatment may involve one or a combination of these options:

Other therapies that are used less commonly, or are not considered standard treatment for prostate cancer, include:

Learn more about treatments for prostate cancer

Testis Cancer

Testicular cancer most often begins in germ cells (cells that make sperm). It is uncommon and is most frequently diagnosed in men ages 20 to 34. Most testicular cancers can be cured, even if diagnosed at an advanced stage.

What are the risk factors?

These include:

  • Cryptorchidism or testicular maldescent.
  • Klinefelter’s syndrome.
  • Family history.
  • Male infertility (increases risk by a factor of three).
  • Low birth weight, young maternal age, young paternal age, multiparity, breech delivery.
  • Infantile hernia.
  • Height – taller men are more at risk of developing germ cell tumours.

Of the factors associated with the risk of developing germ cell tumours of the testis, cryptorchism and malignancy in the contralateral testis are by far the strongest. Testicular microlithiasis, vasectomy, and scrotal trauma are not risk factors for testicular cancer.

What are the common symptoms of testicular cancer?

The common symptoms of testicular tumor are:

  • More than 95% present with a lump in the body of the testis, which is usually painless. Lumps in the Groin and Scrotum 
  • Testicular pain and/or abdominal pain.
  • Dragging sensation.
  • Recent history of trauma; it is probably the trauma that leads the man to examine himself and find the tumour rather than being the cause of malignant change.
  • Hydrocele.
  • Gynaecomastia from beta human chorionic gonadotrophin (beta-hCG) production.
  • Metastasis – seminomas metastasise to para-aortic nodes and produce back pain; teratomas undergo blood-borne spread to the liver, lung, bone and brain.

How is testicular cancer diagnosed?

Patients should seek an urgent consultation if they suspect abnormalities in the testis. The common diagnostic tests are:

  • Diagnosis is usually confirmed by ultrasound.
  • Tissue histology can follow an inguinal orchidectomy.
  • Disease can be staged by thoraco-abdominal CT scanning.
  • Elevation of tumour markers supports the diagnosis but normal marker levels do not exclude testicular cancer and these markers are raised in other cancers and some benign conditions:
    • Alpha-fetoprotein (AFP) is produced by yolk sac elements but not produced by seminomas.
    • Beta-hCG is produced by trophoblastic elements and so there may be elevated levels both in teratomas and in seminomas.

What are the treatment options?

Management is dependent on the type of tumour and stage. Approximately 90% of patients classified as having a good prognosis achieve a durable complete remission with treatment. Even metastatic disease should be seen as potentially curable. When treating young adults with a highly curable disease, possible long-term toxicity of treatment is an important consideration. Following confirmation of a germ cell tumour, all patients should be referred to a specialist centre for the management of testicular tumours.

Where possible, a radical orchidectomy should be performed. A testicular prosthesis should be offered to all patients. When appropriate, sperm storage should be offered to men who may require chemotherapy or radiotherapy.

Patients with metastases where the diagnosis is not in doubt (high tumour markers and the presence of a testicular mass) should be referred for immediate chemotherapy

Do patients need follow-up after treatment?

All patients post treatment of testis cancer will need a strict follow-up. Your doctor will schedule you for regular visits after treatment to see if the cancer has come back (recurrence). Visits may include a physical examination, blood tests, chest x-ray, and/or a CT scan to look for new tumors. Visits are usually more frequent just after treatment ends. Follow-up typically continues for at least 5 years. If there is no recurrence, you do not need further treatment.

Examining your testicles is easy

Examine your testicles regularly (Fig. below), especially if you have a risk factor for testicular cancer.

The best time to examine your testicles is right after a hot bath or shower. The scrotal skin will be relaxed, and the testicles can be felt more easily. It takes only a few minutes.

Do the exam standing:

  • Look for swelling in the scrotum.
  • Gently feel the scrotal sac to find a testicle.
  • Examine the testicles one at a time. Firmly and gently feel each testicle between the thumb and fingers of both hands over the whole surface.
  • It is normal for one testicle to be slightly larger than the other. It is also normal to feel a cord-like structure (the epididymis) on the top and back of each testicle.

If you find a lump, swelling, or other change, see you doctor. Changes are not always cancer, but if it is cancer and you catch it early, you have the best chance of cure.

Bladder Cancer

Bladder cancer is a common type of cancer that involves the bladder. Most often the cancer starts in the cells (urothelial cells) that line the inside of your bladder. Urothelial cells are also found in the kidneys and the tubes (ureters) that connect the kidneys to the bladder. Urothelial cancer can also happen in the kidneys and ureters, although less frequent than in the bladder.

What cause bladder cancer?

Till date it is unclear what causes bladder cancer. A number of risk factors have been identified, but in many cases none of them may be present. (Risk factor is not a cause in itself but increases the risk that a cancer may occur). The risk factors are:

  • Smoking. Smoking cigarettes, cigars or pipes may increase the risk of bladder cancer by causing harmful chemicals to accumulate in the urine. This is the most important risk factor for bladder cancer. Stopping smoking for 4 years may lower the risk.
  • Increasing age. Bladder cancer risk increases as you age. Overall, 70% of patients detected with bladder cancer are older than 55, though it can occur at any age.
  • Being male. Men are more likely to develop bladder cancer than women are.
  • Exposure to certain chemicals.  Chemicals linked to bladder cancer risk include arsenic and chemicals used in the manufacture of dyes, rubber, leather, textiles and paint products. Certain professionals like truck drivers, dry cleaners, dental technicians, and hairdressers are at increased risk of bladder cancer due to exposure to Aromatic Amines at work. Use of Aristolochia fangchi (a Chinese herb used in certain dietary supplements and herbal remedies) is also linked with bladder cancer.
  • Previous cancer treatment. Treatment with the anti-cancer drug cyclophosphamide and radiation treatments aimed at treating pelvic cancers increase the risk of developing bladder cancer at a later age.
  • Chronic bladder inflammation. Chronic or repeated urinary infections or inflammations (cystitis), such as might happen with long-term use of a urinary catheter, may increase the risk of a squamous cell bladder cancer. A parasitic infection, Schistosomiasis, seen In some areas of the world, is also linked to this type of bladder cancer.
  • Personal or family history of cancer. If you’ve had bladder cancer, you’re more likely to get it again. A family history of Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), can increase the risk of cancer in the urinary system, as well as in the colon, uterus, ovaries and other organs.
  • Diabetes. Individuals with Type 2 diabetes have an increased risk of developing bladder cancer.

How is bladder cancer diagnosed?

Tests and procedures used to diagnose bladder cancer may include:

  • Cystoscopy. Using am endoscope to examine the inside of your bladder (cystoscopy).  Based on the findings at cystoscopy, a sample of tissue may be removed for testing (biopsy). If this tissue under microscopic examination reveals bladder cancer, the cancer is classified based on how the cancer cells appear in microscopic view-This is known as the grade, and the bladder cancer is classified as either low grade or high grade:
  • Low-grade bladder cancer. The cancer cells are closer in appearance and organization to normal cells (well differentiated). These tumors usually grow more slowly and is less likely to invade the muscular wall of the bladder.
  • High-grade bladder cancer. The cancer cells are abnormal-looking and lack any resemblance to normal-appearing tissues (poorly differentiated). These tumors grow more aggressively and more likely to spread to the muscular wall of the bladder and other tissues and organs.
  • Urine cytology. A sample of urine is analyzed under a microscope to check for cancer cells in a procedure called urine cytology.
  • Imaging tests. Imaging tests, such as computerized tomography (CT) urogram or retrograde pyelogram (RGP), allow to examine the structures of your urinary tract.

After confirming bladder cancer, additional tests may be recommended to determine whether the cancer has spread to your lymph nodes or to other areas of your body. These include:

  • CT scan
  • Magnetic resonance imaging (MRI)
  • Positron emission tomography (PET)
  • Bone scan
  • Chest X-ray

What are the available treatment options?

Treatment options for bladder cancer depend on a number of factors, including the type of cancer, grade of the cancer and stage of the cancer, overall health of the affected individual and his treatment preferences

The options are:

Surgery, to remove the cancer cells. Common types of surgery for bladder cancer are:

  • Surgery, to remove the cancer cells. Common types of surgery for bladder cancer are:

    Transurethral resection of bladder tumor (TURBT). An endoscopic surgery to diagnose and remove cancers confined to the inner layers of the bladder, usually performed for cancers that aren’t yet muscle-invasive cancers. This may be performed using laser technology.

    Cystectomy. A surgery to remove all or part of the bladder that may be undertaken by open, laparoscopic or robotic technology. Partial cystectomy is a procedure where the surgeon removes only the portion of the bladder that contains a single cancerous tumor. Radical cystectomy is an operation to remove the entire bladder and the surrounding lymph nodes. After radical cystectomy a new way of urine storage and expulsion needs to be created using segments of intestine, called urinary diversion (different techniques are neobladder, ileal conduit, continent diversion).

  • Chemotherapy in the bladder (intravesical chemotherapy), to treat cancers that are confined to the lining of the bladder but have a high risk of recurrence or progression to a higher stage.
  • Chemotherapy for the whole body (systemic chemotherapy), to increase the chance for a cure in a person having surgery to remove the bladder, or as a primary treatment when surgery isn’t an option.
  • Radiation therapy, to destroy cancer cells, often as a primary treatment when surgery isn’t an option or isn’t desired.
  • Immunotherapy, to trigger the body’s immune system to fight cancer cells, either in the bladder or throughout the body
  • Targeted therapy, to treat advanced cancer when other treatments haven’t helped

A combination of treatment approaches may be recommended by your doctor and members of your care team.

What measures can be followed to reduce the risk of bladder cancer?

Although there’s no guaranteed way to prevent bladder cancer, few steps can help to reduce bladder cancer risk.

  • Don’t smoke. If you don’t smoke, don’t start. If you smoke, talk to your doctor about a plan to help you stop. Support groups, medications and other methods may help you quit.
  • Fluid Intake. Certain studies have shown that a high fluid intake may reduce the risk of developing bladder cancer.
  • Take caution around chemicals. If you work with chemicals, follow all safety instructions to avoid exposure.
  • Choose a variety of fruits and vegetables. Choose a diet rich in a variety of colorful fruits and vegetables. The antioxidants in fruits and vegetables may help reduce your risk of cancer.

Living as a Bladder Cancer Survivor

Second Cancers After Bladder Cancer

Thank you for visiting our site today - pls let us know how we can help you?